Virica Biotech
Virica Biotech specializes in developing Viral Sensitizers (VSEs) to enhance viral yields and offers a range of services to support their integration into various production processes.
Viral Sensitizers (VSEs) Library
Virica Biotech has developed a comprehensive library of over 100 proprietary Viral Sensitizers (VSEs). These VSEs are aimed at improving viral yields by mitigating antiviral defenses at a cellular level. The extensive range of VSEs has been evaluated in over 50 applications, optimizing viral titer and vector quality attributes across various cell lines and viral products. This dedication to innovation highlights Virica Biotech's contribution to enhancing viral production efficiency.
Services
Virica Biotech provides a variety of services to help clients integrate VSEs into their processes. These services include analytical services to evaluate the efficacy of VSEs, regulatory filing support to navigate compliance challenges, and scale-up or tech transfer services to ensure seamless implementation. Additionally, Virica offers development services to create customized VSE formulations tailored to specific viral production platforms, employing high-throughput methodologies for optimum results.
NIIMBL Project for CAR-T Manufacturing
Virica Biotech was awarded a project by the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) to enhance CAR-T manufacturing. This project focuses on increasing lentiviral vector production outputs and improving the overall efficiency of CAR-T manufacturing by utilizing small-molecule enhancers. The award underscores Virica Biotech's commitment to advancing manufacturing technologies in the biopharmaceutical sector.